Insights into COVID-19 Delta variant (B.1.617.2)
Since beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), different variants of concern (VOC) have been discovered. One of the variants that stood out was the Delta variant (B.1.617.2), first found in India. It caught worldwide attention due to its greater transmissibilit...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
HH Publisher
2021-11-01
|
| Series: | Progress in Microbes and Molecular Biology |
| Online Access: | https://journals.hh-publisher.com/index.php/pmmb/article/view/509 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832541405920100352 |
|---|---|
| author | Angel Yun-Kuan Thye Ke-Yan Loo Kyle Bond Chene Tan Jenny May-Sim Lau Vengadesh Letchumanan |
| author_facet | Angel Yun-Kuan Thye Ke-Yan Loo Kyle Bond Chene Tan Jenny May-Sim Lau Vengadesh Letchumanan |
| author_sort | Angel Yun-Kuan Thye |
| collection | DOAJ |
| description |
Since beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), different variants of concern (VOC) have been discovered. One of the variants that stood out was the Delta variant (B.1.617.2), first found in India. It caught worldwide attention due to its greater transmissibility than the progenitor strain and the first variant of concern (VOC)- Alpha variant (B.1.1.7). B.1.617.2 spread rapidly across the globe and became a VOC due to its high transmissibility, clinical implications, and impact on vaccine efficacy. This review discusses the background and prevalence of B.1.617.2 and its sensitivity to convalescent sera and vaccinated individuals. We will provide an insight into the impact B.1.617.2 has on vaccine efficacy and discuss the level and type of protection an individual could get by being vaccinated. We will also discuss briefly on the COVID-19 vaccine booster doses and whether it is needed.
|
| format | Article |
| id | doaj-art-5f129048c6074ed7b556c8ac04ad558f |
| institution | Kabale University |
| issn | 2637-1049 |
| language | English |
| publishDate | 2021-11-01 |
| publisher | HH Publisher |
| record_format | Article |
| series | Progress in Microbes and Molecular Biology |
| spelling | doaj-art-5f129048c6074ed7b556c8ac04ad558f2025-02-04T08:40:12ZengHH PublisherProgress in Microbes and Molecular Biology2637-10492021-11-014110.36877/pmmb.a0000243Insights into COVID-19 Delta variant (B.1.617.2)Angel Yun-Kuan Thye0Ke-Yan Loo1Kyle Bond Chene Tan2Jenny May-Sim Lau3Vengadesh Letchumanan4Monash University MalaysiaMonash University MalaysiaNorthern Ireland Centre for Stratified MedicineQueen’s University BelfastMonash University Malaysia Since beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), different variants of concern (VOC) have been discovered. One of the variants that stood out was the Delta variant (B.1.617.2), first found in India. It caught worldwide attention due to its greater transmissibility than the progenitor strain and the first variant of concern (VOC)- Alpha variant (B.1.1.7). B.1.617.2 spread rapidly across the globe and became a VOC due to its high transmissibility, clinical implications, and impact on vaccine efficacy. This review discusses the background and prevalence of B.1.617.2 and its sensitivity to convalescent sera and vaccinated individuals. We will provide an insight into the impact B.1.617.2 has on vaccine efficacy and discuss the level and type of protection an individual could get by being vaccinated. We will also discuss briefly on the COVID-19 vaccine booster doses and whether it is needed. https://journals.hh-publisher.com/index.php/pmmb/article/view/509 |
| spellingShingle | Angel Yun-Kuan Thye Ke-Yan Loo Kyle Bond Chene Tan Jenny May-Sim Lau Vengadesh Letchumanan Insights into COVID-19 Delta variant (B.1.617.2) Progress in Microbes and Molecular Biology |
| title | Insights into COVID-19 Delta variant (B.1.617.2) |
| title_full | Insights into COVID-19 Delta variant (B.1.617.2) |
| title_fullStr | Insights into COVID-19 Delta variant (B.1.617.2) |
| title_full_unstemmed | Insights into COVID-19 Delta variant (B.1.617.2) |
| title_short | Insights into COVID-19 Delta variant (B.1.617.2) |
| title_sort | insights into covid 19 delta variant b 1 617 2 |
| url | https://journals.hh-publisher.com/index.php/pmmb/article/view/509 |
| work_keys_str_mv | AT angelyunkuanthye insightsintocovid19deltavariantb16172 AT keyanloo insightsintocovid19deltavariantb16172 AT kylebondchenetan insightsintocovid19deltavariantb16172 AT jennymaysimlau insightsintocovid19deltavariantb16172 AT vengadeshletchumanan insightsintocovid19deltavariantb16172 |